Mauricio Tohen
#4,779
Most Influential Person Now
Researcher
Mauricio Tohen's AcademicInfluence.com Rankings
Download Badge
Biology
Mauricio Tohen's Degrees
- Doctorate Medicine University of Barcelona
- PhD Psychiatry University of Barcelona
Why Is Mauricio Tohen Influential?
(Suggest an Edit or Addition)According to Wikipedia, Mauricio Tohen is a Mexican American research psychiatrist, Distinguished Professor, and Chairman of the Department of Psychiatry & Behavioral Sciences at the University of New Mexico. Tohen's research has focused on the epidemiology, outcome, and treatment of bipolar and psychotic disorders, and is especially known for innovating the design of clinical trials and the criteria to determine outcome in such diseases. Tohen has edited several books on his specialties. His social awareness has been noted in the promotion of programs to improve mental health care in areas such as substance abuse, bipolar disorder and schizophrenia.
Mauricio Tohen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. (2003) (819)
- Antipsychotic drug effects on brain morphology in first-episode psychosis. (2005) (752)
- One hundred years of schizophrenia: a meta-analysis of the outcome literature. (1994) (603)
- Olanzapine versus placebo in the treatment of acute mania (1998) (591)
- Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. (2000) (571)
- The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. (2013) (551)
- Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. (2006) (541)
- Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis. (1990) (537)
- A novel augmentation strategy for treating resistant major depression. (2001) (497)
- Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. (2000) (496)
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression. (2015) (449)
- The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. (2003) (442)
- Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. (2002) (418)
- Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. (2003) (407)
- One hundred years of schizophrenia: A meta-analysis of the outcome literature (1993) (398)
- Textbook in psychiatric epidemiology (2002) (392)
- The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. (2009) (388)
- Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. (1991) (371)
- Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. (2005) (332)
- Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. (1998) (319)
- Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. (2004) (303)
- Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. (2006) (294)
- Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone (2004) (288)
- A double-blind trial of bupropion versus desipramine for bipolar depression. (1994) (276)
- Olanzapine versus divalproex in the treatment of acute mania. (2002) (258)
- Olanzapine versus placebo in the treatment of adolescents with bipolar mania. (2007) (247)
- Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. (1997) (242)
- A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. (2003) (236)
- A Double-Blind, Randomized Comparison of the Efficacy and Safety of Intramuscular Injections of Olanzapine, Lorazepam, or Placebo in Treating Acutely Agitated Patients Diagnosed With Bipolar Mania (2001) (235)
- The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis I. Study rationale and design (2003) (232)
- Functional Impairment and Cognition in Bipolar Disorder (2004) (230)
- Symptoms and functioning of patients with bipolar disorder six months after hospitalization. (1988) (220)
- Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. (1993) (216)
- A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. (2001) (213)
- Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: A 47-week study (2001) (211)
- Structural brain abnormalities in first-episode mania (1993) (208)
- Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome (2003) (204)
- First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol (2004) (199)
- Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol (2005) (199)
- Risk and Protective Factors in the Development of Psychopathology (1995) (194)
- The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis II. Baseline characteristics of the “prodromal” sample (2003) (191)
- First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P300 amplitude over left temporal lobe. (1998) (190)
- Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia. (2002) (189)
- Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. (2011) (179)
- Early Intervention in Bipolar Disorder. (2018) (177)
- A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. (2006) (173)
- Lithium treatment and risk of suicidal behavior in bipolar disorder patients. (1998) (172)
- Predictors of antipsychotic treatment response in patients with first episode schizophrenia, schizoaffective, and schizophreniform disorders (2003) (169)
- The McLean–Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis (2000) (162)
- Racial differences in the diagnosis of psychosis (1996) (161)
- Comorbidity in psychosis at first hospitalization. (1993) (159)
- Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode (2006) (156)
- MRI study of cavum septi pellucidi in schizophrenia, affective disorder, and schizotypal personality disorder. (1998) (150)
- McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. (2009) (146)
- Medication compliance among patients with bipolar disorder and substance use disorder. (1998) (146)
- Bipolar Depression: Overview and Commentary (2010) (145)
- Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. (2003) (144)
- Comorbidity in mania at first hospitalization. (1992) (144)
- An excitement subscale of the Positive and Negative Syndrome Scale (2004) (144)
- Antidepressant-associated mania: a controlled comparison with spontaneous mania. (1994) (141)
- Olanzapine Versus Haloperidol Treatment in First-Episode Psychosis (1999) (141)
- First-episode mania in late life. (1994) (141)
- Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. (1994) (137)
- Is clozapine a mood stabilizer? (1995) (137)
- Four-year follow-up of twenty-four first-episode manic patients. (1990) (135)
- The Bipolar Depression Rating Scale (BDRS): its development, validation and utility. (2007) (135)
- Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients. (2004) (132)
- Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial. (2009) (128)
- Olanzapine and haloperidol in first episode psychosis: Two-year data (2006) (127)
- The deficit syndrome in the DSM-IV field trial: I. Alcohol and other drug abuse (1996) (127)
- Predominant recurrence polarity among 928 adult international bipolar I disorder patients (2012) (123)
- Clozapine in the treatment of refractory psychotic mania. (2000) (123)
- Mania compared with unipolar depression in old age. (1992) (123)
- Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features. (1992) (123)
- A Double-Blind, Randomized Study of Olanzapine and Olanzapine/Fluoxetine Combination for Major Depression With Psychotic Features (2004) (122)
- Childhood Abuse in First-Episode Psychosis (1994) (121)
- The Effect of Comorbid Substance Use Disorders on the Course of Bipolar Disorder: A Review (1998) (121)
- Long-Term Neurocognitive Effects of Olanzapine or Low-Dose Haloperidol in First-Episode Psychosis (2006) (119)
- Clozapine in severe mood disorders. (1995) (119)
- The McLean First-Episode Psychosis Project: six-month recovery and recurrence outcome. (1992) (119)
- Insight in first-episode psychosis (2006) (119)
- Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk. (1995) (118)
- Time-lapse mapping of cortical changes in schizophrenia with different treatments. (2009) (117)
- Morbidity in 303 first-episode bipolar I disorder patients. (2010) (116)
- Substance abuse in first-episode bipolar I disorder: indications for early intervention. (2005) (111)
- Risperidone in the treatment of mania. (1996) (108)
- Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study. (2001) (106)
- Predicting the course and outcome of bipolar disorder: A review (2010) (105)
- Reduced Amygdala Volumes in First-Episode Bipolar Disorder and Correlation with Cerebral White Matter (2007) (104)
- Antipsychotic agents and bipolar disorder. (1998) (102)
- Extent of comorbidity between mental state and personality disorders. (1997) (100)
- Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial. (2006) (97)
- A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes. (2015) (97)
- McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients. (2011) (97)
- Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression. (2012) (96)
- Stigma and functioning in patients with bipolar disorder. (2011) (93)
- Onset-age of bipolar disorders at six international sites. (2010) (93)
- Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. (2008) (90)
- Olanzapine versus haloperidol in the treatment of first episode psychosis (1998) (90)
- Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. (1995) (89)
- Epidemiology of Bipolar Disorder (2003) (88)
- Neuropsychological course in the prodrome and first episode of psychosis: Findings from the PRIME North America Double Blind Treatment Study (2008) (86)
- Risperidone in the elderly: a pharmacoepidemiologic study. (1997) (85)
- Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder. (2013) (84)
- Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study. (2000) (84)
- Pre- and perinatal complications and risk for bipolar disorder: a retrospective study. (1998) (84)
- Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes. (2006) (83)
- Sex differences in clinical response to olanzapine compared with haloperidol (2002) (82)
- Open trial of S-adenosylmethionine for treatment of depression. (1984) (80)
- The empirical redefinition of the psychometric criteria for remission in bipolar disorder. (2008) (79)
- Influence of sub-syndromal symptoms after remission from manic or mixed episodes (2006) (79)
- Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania. (2003) (78)
- Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. (2008) (78)
- Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972-1988. (1993) (77)
- Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania. (2008) (77)
- Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data. (2004) (76)
- Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes (2008) (75)
- Ecological Studies of Antidepressant Treatment and Suicidal Risks (2007) (75)
- Olanzapine Versus Placebo in Acute Mania: Treatment Responses in Subgroups (2003) (74)
- MRI subcortical signal hyperintensities in Mania at first hospitalization (1993) (74)
- An empirical study of psychosis in borderline personality disorder. (1985) (73)
- Acute Dysphoric Mania: Treatment Response to Olanzapine Versus Placebo (2003) (73)
- Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). (2015) (73)
- Episode sequence in bipolar disorder and response to lithium treatment. (1991) (72)
- Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status (2002) (72)
- Young Mania Rating Scale: how to interpret the numbers? Determination of a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort (2013) (72)
- What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium (2019) (71)
- Olanzapine as Long-Term Adjunctive Therapy in Treatment-Resistant Bipolar Disorder (2001) (71)
- Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors. (2008) (70)
- The deficit syndrome in the DSM-IV field trial Part II. Depressive episodes and persecutory beliefs (1996) (69)
- Summer birth and the deficit syndrome of schizophrenia. (1998) (68)
- Extracting spurious messages from noise and risk of schizophrenia-spectrum disorders in a prodromal population (2007) (68)
- A meta-analysis of the use of typical antipsychotic agents in bipolar disorder. (2001) (68)
- Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline? (1996) (67)
- Maintenance treatment in bipolar disorder. (2000) (67)
- Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling. (2003) (66)
- Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. (2008) (66)
- Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression. (2009) (65)
- Concurrent use of clozapine and valproate in affective and psychotic disorders. (1994) (65)
- Discontinuation of Maintenance Treatment in Bipolar Disorder: Risks and Implications (1993) (65)
- Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial. (2004) (64)
- Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. (2009) (64)
- Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. (2009) (63)
- Possible affective-state dependence of the tridimensional personality questionnaire in first-episode psychosis (1992) (63)
- Scale matters: the need for a Bipolar Depression Rating Scale (BDRS) (2004) (62)
- Effect of comorbid anxiety on treatment response in bipolar depression. (2007) (62)
- Telephone versus In‐Person Clinical and Health Status Assessment Interviews in Patients with Bipolar Disorder (1997) (62)
- Two-year outcomes in first-episode psychotic depression the McLean-Harvard First-Episode Project. (2012) (62)
- Clinical predictors of acute response with olanzapine in psychotic mood disorders. (1998) (62)
- Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania. (2004) (61)
- Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder. (2016) (61)
- Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis. (2015) (61)
- Factors modifying drug and placebo responses in randomized trials for bipolar mania. (2011) (60)
- Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): A pragmatic trial of complex treatment for a complex disorder (2014) (60)
- The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: a pharmacoepidemiology study. (1999) (58)
- Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trial. (2002) (58)
- Antipsychotic agents in the treatment of bipolar mania. (2009) (56)
- DSM-5 mixed specifier for manic episodes: evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data. (2013) (56)
- Dissimilar morbidity following initial mania versus mixed-states in type-I bipolar disorder. (2010) (55)
- Tardive dyskinesia and the 3-year course of schizophrenia: results from a large, prospective, naturalistic study. (2008) (55)
- Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression. (2011) (54)
- Results of the COVID-19 mental health international for the general population (COMET-G) study (2021) (53)
- Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression. (2005) (53)
- Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders. (1994) (52)
- Longitudinal research on bipolar disorders (2007) (52)
- The tridimensional personality questionnaire as a predictor of six-month outcome in first episode mania (1993) (51)
- Recovery and functional outcomes following olanzapine treatment for bipolar I mania. (2005) (51)
- Long-term response to carbamazepine: a retrospective study. (1988) (50)
- A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression. (2006) (49)
- Weight gain during treatment of bipolar I patients with olanzapine. (2004) (49)
- An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder (2019) (48)
- Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania. (2010) (48)
- Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis. (2010) (48)
- Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex. (2006) (48)
- Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study. (2008) (48)
- The relationship between affective state and the rhythmicity of activity in bipolar disorder. (2014) (47)
- Comparison of treatment-emergent extrapyramidal symptoms in patients with bipolar mania or schizophrenia during olanzapine clinical trials. (2006) (46)
- Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder (2016) (46)
- Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies. (2010) (45)
- Neuroimaging Biomarkers in Schizophrenia. (2021) (44)
- Episode cycles with increasing recurrences in first-episode bipolar-I disorder patients. (2012) (44)
- Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder. (2009) (44)
- Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders. (2014) (44)
- Mood disorders across the life span (1996) (43)
- Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data. (2005) (43)
- Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders. (2015) (43)
- Treatment of Bipolar I Rapid Cycling Patients During Dysphoric Mania with Olanzapine (2002) (42)
- Unipolar Mania Reconsidered: Evidence from an Elderly Cohort (1994) (42)
- First-episode schizophreniform disorder: comparisons with first-episode schizophrenia (2000) (42)
- Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic features. (2003) (42)
- High risk of eosinophilia in women treated with clozapine. (1993) (41)
- Increasing frequency of the diagnosis of obsessive-compulsive disorder. (1992) (41)
- Heuristic models of comorbidity of axis I and axis II disorders. (1997) (40)
- Olanzapine for Psychotic Conditions in the Elderly (2000) (40)
- The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review (2020) (40)
- Functional outcome assessment in bipolar disorder: A systematic literature review (2019) (39)
- Combined Valproate or Carbamazepine and Electroconvulsive Therapy (1997) (39)
- Olanzapine as Alternative Therapy for Patients With Haloperidol-Induced Extrapyramidal Symptoms: Results of a Multicenter, Collaborative Trial in Latin America (2001) (39)
- Harnessing the potential of community-based participatory research approaches in bipolar disorder (2016) (39)
- Acute risk factors for suicide attempts and death: prospective findings from the STEP‐BD study (2016) (39)
- Efficacy of olanzapine monotherapy in the treatment of bipolar depression with mixed features. (2014) (39)
- Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders. (1994) (38)
- Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder (2014) (37)
- Management of acute mania. (1999) (37)
- Dr. Stoll and Colleagues Reply (1993) (37)
- Predicting diagnostic change among patients diagnosed with first-episode DSM-IV-TR major depressive disorder with psychotic features. (2013) (36)
- Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study (2019) (35)
- Olanzapine vs placebo in the treatment of acute mania (1998) (34)
- Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid. (2004) (34)
- Efficacy of olanzapine monotherapy in acute bipolar depression: a pooled analysis of controlled studies. (2013) (34)
- Effectiveness and Safety of the Combination of Fluoxetine and Olanzapine in Outpatients With Bipolar Depression: An Open-Label, Randomized, Flexible-Dose Study in Puerto Rico (2009) (34)
- Onset of antidepressant effect of olanzapine and olanzapine/fluoxetine combination in bipolar depression. (2007) (34)
- Onset of action of antipsychotics in the treatment of mania. (2000) (34)
- Erratum: First-episode schizophrenic psychosis differs from first- episode affective psychosis and controls in P300 amplitude over left temporal lobe (Archives of General Psychiatry (1998) 55 (173-180)) (1998) (32)
- Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia. (2013) (31)
- The use of valproate in an elderly population with affective symptoms. (1996) (31)
- Antecedents of manic versus other first psychotic episodes in 263 bipolar I disorder patients (2014) (31)
- Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study. (2012) (29)
- Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode (2005) (29)
- Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD Study. (2017) (28)
- Ketamine: stimulating antidepressant treatment? (2016) (27)
- Comorbidity in Affective Disorders (1998) (27)
- Comparison of psychotic bipolar disorder, schizoaffective disorder, and schizophrenia: an international, multisite study (2016) (27)
- Hypothyroidism risk compared among nine common bipolar disorder therapies in a large US cohort (2016) (27)
- P.1.092 Olanzapine versus lithium in relapse prevention in bipolar disorder: A randomized double-blind controlled 12-month clinical trial (2003) (27)
- Psychopathology factors in first-episode affective and non-affective psychotic disorders. (2007) (27)
- P.1.091 Olanzapine's efficacy for relapse prevention in bipolar disorder: A randomized double-blind placebo-controlled 12-month clinical trial (2003) (27)
- Thyroid function tests in first-episode bipolar disorder manic and mixed types (1997) (26)
- Efficacy of olanzapine in the treatment of bipolar mania with mixed features defined by DSM-5. (2014) (26)
- Substance abuse in psychotic disorders: associations with affective syndromes (1994) (26)
- Capgras' Syndrome in First-Episode Psychotic Disorders (2014) (26)
- Social media recruitment for mental health research: A systematic review. (2020) (26)
- EEG abnormalities before clozapine therapy predict a good clinical response to clozapine. (1996) (26)
- AACAP 2006 Research Forum--Advancing research in early-onset bipolar disorder: barriers and suggestions. (2009) (25)
- Use of olanzapine in dysphoric mania. (2001) (25)
- Pharmacotherapy patterns in the treatment of bipolar disorder. (2002) (25)
- Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial* (2005) (24)
- Predictors of relapse or recurrence in bipolar I disorder. (2012) (23)
- The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder (2019) (23)
- Thrombocytopenia associated with carbamazepine: a case series. (1991) (23)
- Prescribing trends of antidepressants in bipolar depression. (1995) (23)
- Long-term efficacy and safety of atypical and conventional antipsychotic drugs in first episode schizophrenia (2003) (23)
- White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder (2017) (23)
- Olanzapine versus haloperidol in schizoaffective disorder, bipolar type. (2001) (23)
- Outcomes for Latin American Versus White Patients Suffering From Acute Mania in a Randomized, Double-Blind Trial Comparing Olanzapine and Haloperidol (2007) (22)
- Clinical relevance of depressive symptom improvement in bipolar I depressed patients. (2006) (22)
- Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study. (2016) (22)
- Improvement of positive and negative syndrome scale cognitive score associated with olanzapine treatment of acute mania (2004) (21)
- Brief communication: pathological narcissism in bipolar disorder patients. (1998) (21)
- Psychotherapy use in bipolar disorder: Association with functioning and illness severity (2015) (21)
- Complexity of Illness and Adjunctive Benzodiazepine Use in Outpatients With Bipolar I or II Disorder: Results From the Bipolar CHOICE Study (2015) (20)
- Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors. (2019) (20)
- In search of optimal lithium levels and olanzapine doses in the long-term treatment of bipolar I disorder. A post-hoc analysis of the maintenance study by Tohen et al. 2005 (2010) (20)
- Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force (2021) (20)
- Bipolar psychopharmacotherapy : caring for the patient (2006) (20)
- Cycling into depression from a first episode of mania: a case-comparison study. (2001) (19)
- Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study (2013) (18)
- Long‐term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithms (2020) (18)
- What makes a drug a primary mood stabilizer? (2002) (18)
- Reviewing CATIE for clinicians:balancing benefit and risk using evidence-based medicine tools (2007) (18)
- Comorbidity in Bipolar Disorder (2009) (18)
- The McLean/Harvard First-Episode Mania Project: Pharmacologic Treatment and Outcome (1996) (17)
- Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial. (2018) (17)
- Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes (2006) (17)
- A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report. (2016) (17)
- Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses (2022) (17)
- Cultural influences on suicide in Japan (2017) (17)
- Systemic challenges in bipolar disorder management: A patient‐centered approach (2017) (16)
- Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial. (2014) (16)
- Advances in bipolar disorder: selected sessions from the 2011 International Conference on Bipolar Disorder (2011) (16)
- Clinical utility of early improvement to predict response or remission in acute mania: focus on olanzapine and risperidone. (2011) (16)
- Olanzapine vs. placebo in rapid-cycling bipolar disorder (1998) (16)
- Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol (American Journal of Psychiatry (2003) 160, (1396-1404)) (2009) (16)
- Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial (2015) (16)
- Switching between Clozapine and Risperidone Treatment (1997) (16)
- Placebo-controlled trials do not find association of olanzapine with exacerbation of bipolar mania. (2003) (16)
- Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes. (2011) (16)
- Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials (2021) (15)
- Patterns of drug treatment for manic episode in the clinical practice. Outcomes of the Spanish sample in the EMBLEM Study. (2007) (15)
- Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder. (2017) (15)
- Olanzapine versus placebo treatment of the schizophrenia prodrome: One year results (2003) (15)
- Clinical correlates of acute bipolar depressive episode with psychosis. (2017) (15)
- Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder (2017) (15)
- Four cases of obstructive sleep apnea associated with treatment-resistant mania. (1991) (15)
- Health-related quality of life as measured by the child health questionnaire in adolescents with bipolar disorder treated with olanzapine. (2012) (14)
- The study of olanzapine plus fluoxetine in treatment-resistant major depressive disorder without psychotic features (2000) (14)
- The impact of binge eating behavior on lithium- and quetiapine-associated changes in body weight, body mass index, and waist circumference during 6 months of treatment: Findings from the bipolar CHOICE study. (2020) (14)
- Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder (2012) (13)
- Multi-state outcome analysis of treatments (MOAT): application of a new approach to evaluate outcomes in longitudinal studies of bipolar disorder (2015) (13)
- A Modified Delphi Consensus Study of the Screening, Diagnosis, and Treatment of Tardive Dyskinesia. (2020) (13)
- Methamphetamine Abuse Trends in Psychiatric Emergency Services: A Retrospective Analysis Using Big Data (2020) (13)
- Antipsychotic treatment effects on progression of brain pathomorphology in first episode schizophrenia (2003) (13)
- The McLean-Harvard First-Episode Project: Early Course in 114 Cases of First-Episode Nonaffective Psychoses. (2016) (12)
- Handbook of Social Functioning in Schizophrenia (1999) (12)
- Bipolar depression and suicidal ideation: Moderators and mediators of a complex relationship. (2019) (12)
- Olanzapine versus placebo in adolescents with schizophrenia (2007) (12)
- Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale. (2019) (12)
- Can a Framework Be Established for the Safe Use of Ketamine? (2018) (12)
- Effects of lithium on sleep in mania (1989) (11)
- Olanzapine combined with mood stabilizers in prevention of recurrence in bipolar disorder: An 18-month study (2002) (11)
- Olanzapine in the treatment of bipolar-disorder in juveniles (2000) (11)
- Olanzapine in the treatment of bipolar depression (2002) (11)
- Is there a long-term protective effect of mood-altering agents in unipolar depressive disorder? (1988) (11)
- Clinical trials in bipolar mania: implications in study design and drug development. (2008) (11)
- The efficacy of cariprazine on function in patients with bipolar depression: a post hoc analysis of a randomized controlled trial (2021) (11)
- Aggression among 216 patients with a first-psychotic episode of bipolar I disorder (2018) (11)
- Negative Affective Features in 516 Cases of First Psychotic Disorder Episodes: Relationship to Suicidal Risk. (2013) (10)
- Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder (2019) (10)
- Olanzapine plus fluoxetine: Double-blind and open-label results in treatment-resistant major depressive disorder (1999) (10)
- The association between mood state and chronobiological characteristics in bipolar I disorder: a naturalistic, variable cluster analysis-based study (2018) (10)
- Epidemiology of Bipolar Disorder in Adults and Children (2011) (9)
- Clinical trial design challenges in mood disorders (2015) (9)
- The International Society of Bipolar Disorders (ISBD) task force on the nomenclature of course and outcome in bipolar disorders (2010) (9)
- Analysis of bipolar maintenance treatment with lithium versus olanzapine utilizing Multi‐state Outcome Analysis of Treatments (MOAT) (2016) (9)
- Bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study. (2017) (9)
- Shifts in hospital diagnostic frequencies: bipolar disorder subtypes, 1981-1993. (1997) (9)
- Olanzapine vs divalproex: Prospective comparison on self-reported cognitive function in patients with bipolar disorder (2002) (9)
- Current status and future perspectives for psychiatry/mental health research in Latin America (2010) (9)
- Olanzapine - relapse prevention following mania (2006) (8)
- Nonsteroidal anti‐inflammatory drugs (NSAIDs) and paracetamol do not affect 6‐month mood‐stabilizing treatment outcome among 482 patients with bipolar disorder (2017) (8)
- Variables as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study. (2012) (8)
- Patient Characteristics Associated With Use of Lurasidone Versus Other Atypical Antipsychotics in Patients With Bipolar Disorder: Analysis From a Claims Database in the United States. (2017) (8)
- Identifying Profiles of Patients With Bipolar I Disorder Who Would Benefit From Maintenance Therapy With a Long-Acting Injectable Antipsychotic. (2020) (8)
- Comparison of 71 bipolar disorder pharmacotherapies for kidney disorder risk: The potential hazards of polypharmacy. (2019) (8)
- Bipolar Disorder and Comorbid Substance Use Disorders (2001) (7)
- The McLean-Harvard First Episode Project: Two-year Stability of DSM-IV Diagnoses in 500 First-Episode Psychotic Disorder Patients (2009) (7)
- Conflicts of interest and the credibility of psychiatric research. (2007) (7)
- Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM study. (2009) (7)
- Olanzapine-fluoxetine combination for psychotic major depression (2002) (7)
- Familial severe psychiatric history in bipolar disorder and correlation with disease severity and treatment response. (2020) (7)
- The utility, development and validation of the Bipolar Depression Rating Scale (BDRS) (2005) (7)
- Safety and efficacy of olanzapine in the long‐term treatment of Japanese patients with bipolar I disorder, depression: An integrated analysis (2014) (6)
- Efficacy of cariprazine in bipolar I depression across patient characteristics: a post hoc analysis of pooled randomized, placebo-controlled studies (2020) (6)
- Is olanzapine a mood-stabilizer? (2000) (6)
- Increased Glutamate Plus Glutamine in the Right Middle Cingulate in Early Schizophrenia but Not in Bipolar Psychosis: A Whole Brain 1H-MRS Study (2021) (6)
- Olanzapine: Acute and long-term efficacy in bipolar I patients (2000) (6)
- 0466 RESULTS FROM A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF OLANZAPINE IN ADOLESCENTS WITH SCHIZOPHRENIA (2006) (6)
- Occurrence of seizures related to psychotropic medication among psychiatric inpatients. (1995) (6)
- Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study. (2016) (6)
- Treatment outcomes of acute bipolar depressive episode with psychosis (2018) (6)
- Number Needed to Treat or Harm Analyses of Olanzapine for Maintenance Treatment of Bipolar Disorder (2009) (6)
- Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practice (2010) (6)
- The McLean first-episode psychosis project (1993) (6)
- Olanzapine in the treatment of rapid-cycling Bipolar I patients (1999) (6)
- Olanzapine induced reductions in frontal lobe lactate levels correlate with treatment response in first episode psychosis (2003) (6)
- Comprehensive comparison of monotherapies for psychiatric hospitalization risk in bipolar disorders (2018) (6)
- The effect of different degrees of lockdown and self-identified gender on anxiety, depression and suicidality during the COVID-19 pandemic: Data from the international COMET-G study. (2022) (6)
- Safety of the novel antipsychotic olanzapine in the treatment of bipolar I disorder (2000) (6)
- Olanzapine versus divalproex sodium for bipolar mania: a 47-week study (2002) (6)
- Psychiatric collaborations in the Hispanic world. (2014) (6)
- Olanzapine in the treatment of mania: A placebo-controlled four-week study (1999) (6)
- Bipolar Disorders: The use of atypical antipsychotic agents in the treatment of diagnostic subgroups of bipolar disorder: mixed and pure states, psychotic and non-psychotic (2005) (5)
- Olanzapine versus placebo for prodromal symptoms (2003) (5)
- Bias and other methodological issues in follow-up (cohort) studies (1992) (5)
- Biopolar Disorder : The Upswing in Research and Treatment (2005) (5)
- Glutamatergic hypo-function in the left superior and middle temporal gyri in early schizophrenia: a data-driven three-dimensional proton spectroscopic imaging study (2020) (5)
- Introduction to special issue on treatment of bipolar disorder (2003) (5)
- Antipsychotics in acute mania (2000) (5)
- Impact of olanzapine added to lithium or valproate on the quality of life of patients with bipolar disorder (2000) (5)
- Number Needed to Treat (NNT) and Number Needed to Harm (NNH) in Randomized, Blinded Trials Comparing Olanzapine to Other Atypical Antipsychotics for Treatment of Schizophrenia (2008) (5)
- Course and predictors of weight gain in people Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine with first-episode psychosis treated with olanzapine (2005) (5)
- The significance of mania in old age (1992) (5)
- Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trials (2020) (5)
- Treatment Guidelines in Bipolar Disorders and the Importance of Proper Clinical Trial Design (2017) (5)
- 387. Superior temporal gyrus changes over time in first episode schizophrenia (1998) (5)
- Efficacy of olanzapine, fluoxetine and combination therapy in treatment-resistant major depressive disorder without psychotic features (1998) (4)
- THE AMERICAN JOURNAL OF PSYCHIATRY (2015) (4)
- Pharmacologic treatments for borderline personality disorder. (2014) (4)
- Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment response. (2021) (4)
- Cariprazine as a Treatment Option for Depressive Episodes Associated with Bipolar 1 Disorder in Adults: An Evidence-Based Review of Recent Data (2021) (4)
- Electroconvulsive therapy electrode placement for bipolar state-related targeted engagement (2019) (4)
- Childhood trauma and treatment outcomes during mood‐stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder (2022) (4)
- Illness stage and predominant polarity in bipolar disorder: Correlation with burden of illness and moderation of treatment outcome. (2021) (4)
- Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial. (2017) (4)
- A comparison of olanzapine versus risperidone on improvement in negative symptoms and emotional discomfort in patients with schizophrenia (2003) (4)
- Preferences of Information Dissemination on Treatment for Bipolar Disorder: Patient-Centered Focus Group Study (2018) (4)
- Diagnosis and management of bipolar II disorder. (1994) (4)
- Patterns of changes in bipolar depressive symptoms revealed by trajectory analysis among 482 patients with bipolar disorder (2018) (4)
- 323. Subgenual prefrontal cortex reduction in first episode affective psychosis (1998) (4)
- Psychiatric Epidemiology (2000) (4)
- Collaborations between academic psychiatry and the pharmaceutical industry: A perspective from industry (2007) (4)
- Collaboration to Reduce Tragedy and Improve Outcomes: Law Enforcement, Psychiatry, and People Living With Mental Illness. (2017) (4)
- Relationship between African–American or Caucasian origin and outcomes in the olanzapine treatment of acute mania: a pooled analysis of three adult studies conducted in the United States of America (2011) (3)
- Psychiatric epidemiology. (2000) (3)
- Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials (2019) (3)
- Circadian Rhythm and the Prediction of Relapse in Bipolar Disorder. (2017) (3)
- Decreased activation and subsyndromal manic symptoms predict lower remission rates in bipolar depression (2018) (3)
- TC3A EXCESSIVE TOP-DOWN PERCEPTUAL PROCESSING AND REDUCED REAL-WORLD INVESTMENT EXHIBITED BY PRODROMAL PATIENTS PREDICT SUBSEQUENT CONVERSION TO SCHIZOPHRENIA (2006) (3)
- Characteristics of Hispanics Referred to Coordinated Specialty Care for First-Episode Psychosis and Factors Associated With Enrollment. (2021) (3)
- Credibility of industry-funded clinical trials. (2013) (3)
- Prodromal features in first-psychotic episodes of major affective and schizoaffective disorders. (2021) (3)
- Cariprazine in bipolar disorders. (2015) (3)
- Antipsychotic medications in bipolar disorder: a critical review of randomized controlled trials. (2009) (3)
- Long-term olanzapine treatment: Efficacy and safety in manic patients with and without psychotic features (1999) (3)
- Use of electroconvulsive therapy in bipolar depression. (2015) (3)
- Olanzapine in the treatment of juvenile bipolar disorder (2000) (3)
- Neurocognitive effects of olanzapine and low-dose haloperidol: A two-year treatment study in first episode psychosis (2003) (3)
- Onset of action of olanzapine-fluoxetine combination for bipolar depression (2002) (3)
- Olanzapine versus haloperidol: Assessment of cognitive function in patients with schizoaffective disorder, bipolar type (1999) (3)
- White Matter Abnormalities in Late Onset First Episode Mania: A Diffusion Tensor Imaging Study. (2021) (3)
- Olanzapine versus haloperidol in schizoaffective disorder, bipolar type: A repeated measures analysis (1999) (3)
- Depression during mania: treatment response to olanzapine or placebo (2000) (3)
- Understanding Depression: What We Know and What You Can Do About It (2003) (3)
- Methodologies to avoid the enrollment of ineligible patients in clinical trials. (2012) (2)
- Bipolar Disorder and Safety Monitoring for Clinicians: A Review of the Evidence and the Implications (2010) (2)
- Pharmacologic Approaches for TreatmentResistant Mania (1998) (2)
- Sex and neuroendocrine differences in response to treatment with olanzapine: A preliminary analysis (1998) (2)
- Intramuscular olanzapine: Efficacy and safety in acutely agitated patients diagnosed with mania associated with bipolar disorder (2001) (2)
- Drug attitudes and treatment adherence in a clinical trial comparing haloperidol and olanzapine in first episode schizophrenia (2003) (2)
- Commentary on N. Ghaemi's "Hippocratic Psychopharmacology of Bipolar Disorder" Maintenance Treatment in Bipolar Disorder. (2006) (2)
- A double blind study of olanzapine-fluoxetine combination for treatment of psychotic major depression (2001) (2)
- Racial differences in the expression of psychosis (1995) (2)
- Long‐term morbidity in major affective and schizoaffective disorders following hospitalization in first psychotic episodes (2020) (2)
- Putative biological predictors of treatment response in bipolar disorders (2017) (2)
- P.1.078 Long-term use of olanzapine or olanzapine/fluoxetine for bipolar depression (2003) (2)
- Olanzapine versus divalproex sodium for bipolar mania in rapid cyclers (2002) (2)
- Drug-dependent risk of self-harm in patients with bipolar disorder: a comparative effectiveness study using machine learning imputed outcomes. (2021) (2)
- Course and outcome of bipolar disorder — focusing on depressive aspects (2009) (2)
- Real-World Patterns of Utilization and Costs Associated with Second-Generation Oral Antipsychotic Medication for the Treatment of Bipolar Disorder: A Literature Review (2021) (2)
- Lithium plus antipsychotics or anticonvulsants for bipolar disorder: Comparing clinical response and metabolic changes (2022) (2)
- Long-term quality-of-life and economic outcomes associated with the use of olanzapine versus divalproex for acute mania (2001) (2)
- Olanzapine versus placebo in adolescent mania (2007) (1)
- Olanzapine in Schizophrenia and Affective Disorders (2012) (1)
- Olanzapine as an add-on treatment for dysphoric mania in bipolar I rapid cycling patients (2002) (1)
- Erratum: Efficacy of olanzapine in acute bipolar maniana double-blind, placebo-controlled study (Archives of General Psychiatry (2000) 47 (841-849)) (2002) (1)
- Using Machine Learning Imputed Outcomes to Assess Drug-Dependent Risk of Self-Harm in Patients with Bipolar Disorder: A Comparative Effectiveness Study (2021) (1)
- novel strategies to improve generalizability of maintenance trial results in Bipolar Disorder (bd) : 7 (2012) (1)
- A systematic review of interventions in the early course of bipolar disorder I or II: a report of the International Society for Bipolar Disorders Taskforce on early intervention (2023) (1)
- 414 MRI and ERP abnormalities in first episode schizophrenia and affective psychosis (1997) (1)
- Erratum: "Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar i or II disorder: Results from the bipolar CHOICE trial" [Journal of Affective Disorders (2014) 161 (30-35)] (2014) (1)
- Olanzapine versus placebo in rapid-cycling bipolar disorder (1998) (1)
- Asymmetrical P3 topography in first episode schizophrenia-like psychosis (1995) (1)
- Franco Benazzi, M. D. In Memoriam (2009) (1)
- Dr. Tohen Replies (1996) (1)
- Applications of Pharmacoepidemiology in Psychiatry (1994) (1)
- P.1.089 Analysis of treatment-emergent mania with olanzapine/fluoxetine combination (2003) (1)
- 69. Brain CSF volume in patients with first-episode psychosis (1996) (1)
- P.2.d.016 Efficacy of olanzapine monotherapy in the treatment of bipolar depression with varying degrees of manic symptoms (2013) (1)
- 25. Psychiatric Epidemiology (2015) (1)
- Olanzapine in schizophrenia and affective disorders. (2012) (1)
- Bipolar Depression Rating Scale (2011) (1)
- Schizophrenia, season of birth, and phenomenological features (1995) (1)
- Comprar Textbook of psychiatric epidemiology | M. Tsuang | 9780470694671 | Wiley (2011) (1)
- 718 Summer birth and behavioral features in psychotic and nonpsychotic groups (1997) (1)
- Moving the field forward: The impact of research driven educational initiatives on bipolar patients and providers (2006) (1)
- Clinical Trial Design of Maintenance Treatments in Bipolar Disorder (2015) (1)
- Olanzapine as Maintenance Therapy in Patients with Bipolar I Disorder (2007) (1)
- Increased rates of antipsychotic-induced EPS in mood disorders: Myth or reality? (2002) (0)
- Psychotropic agents and the prediction of weight gain. (2015) (0)
- P.1.177 Olanzapine/fluoxetine combination in the treatment of rapid-cycling bipolar depression (2003) (0)
- Course of Bipolar Disorder in Adults and Children (2015) (0)
- Academy of Psychosomatic Medicine: Proceedings From the 50th Annual Meeting November 20-23, 2003, Coronado (San Diego), California (2004) (0)
- Integrative Neuroscience and Personalized Medicine (2011) (0)
- Severity of symptoms in mania-clinical guidelines and study design implications. (2018) (0)
- P165. Circadian Sub-Groups in Bipolar I Disorder (2022) (0)
- Treatment-resistant bipolar disorder: current definitions, epidemiology, and assessment (2015) (0)
- Bipolar Disorders (2000) (0)
- Antipsychotic agents and bipolar disorder. Discussion (1998) (0)
- Analysis of randomized clinical trials with oral and intramuscular (IM) olanzapine in bipolar-affective disorders based on EBM criteria and therapeutic effect calculation (2003) (0)
- Interpreting the Findings of a Meta-analysis of Psychosocial Interventions in Bipolar Disorder. (2021) (0)
- Olanzapine use in bipolar disorder (2008) (0)
- Depressive Morbidity in Bipolar I Disorder. (2006) (0)
- Authors' reply (2013) (0)
- Comparison of Bipolar Disorder Monotherapies for Risk of Psychiatric Hospitalization (2018) (0)
- PMH4: CLINICAL, HUMANISTIC, AND ECONOMIC OUTCOMES ASSOCIATED WITH LONG-TERM TREATMENT OF MANIA WITH OLANZAPINE (2000) (0)
- Abstracts from ASENT 2004 Annual Meeting March 11–13, 2004 (2004) (0)
- MONTh OF BIRTh AND SCHIZOPHRENIA (2006) (0)
- Using Machine Learning Imputed Outcomes to Assess Drug-Dependent Risk of Self-Harm in Patients with Bipolar Disorder: A Comparative Effectiveness Study (Preprint) (2020) (0)
- Depression Across the Spectrum of Mood Disorders : Advanced Strategies in Major Depressive Disorder and Bipolar Disorder (2017) (0)
- Olanzapine in Acute Bipolar Mania (2002) (0)
- Mixed bipolar states at first hospitalization (1994) (0)
- Gender differences in schizophrenia: Findings from the DSM-IV field trials (1995) (0)
- 30 – A comparison of three randomized, double-blind, placebo-controlled studies of olanzapine treatment in adolescent and adult patients with Schizophrenia (2008) (0)
- The need to change from a phenomenological to a target engagement approach. (2017) (0)
- CPNP 2019 Annual Meeting Poster Abstracts (2019) (0)
- Behavioral and pharmacological evaluation of the elevated T-maze (ETM) to study anxiety in mice (2002) (0)
- Author's reply: To PMID 22918966. (2013) (0)
- Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: A hypothesis based on data (2023) (0)
- Disparities in Coded and Imputed Post-Traumatic Stress Disorder and Self-Harm Among US Veterans (2021) (0)
- Design of clinical trials in bipolar disorders (2012) (0)
- Results of the COVID-19 mental health international for the health professionals (COMET-HP) study: depression, suicidal tendencies and conspiracism (2023) (0)
- In Memoriam: Franco Benazzi, MD, 1957-2009 (2009) (0)
- 42 – Number needed to treat (NNT) for all-cause medication discontinuation from randomized controlled trials comparing olanzapine to other antipsychotics for the treatment of schizophrenia (2008) (0)
- Bipolar Depression: Treatment with LATUDA Monotherapy (2015) (0)
- Comparing Medicines for Long-Term Treatment of Bipolar Disorder (2021) (0)
- S112. Does Binge Eating at Baseline Influence Lithium- and Quetiapine-Associated Changes in Anthropometric Measures Over 6 Months of Treatment? Findings From Bipolar Choice (2018) (0)
- Differentiating Major Depressive Disorder and Bipolar Depression (2017) (0)
- PMH22 ECONOMIC OUTCOMES ASSOCIATED WITH OLANZAPINE VERSUS DIVALPROEX TREATMENT FOR ACUTE MANIA: RESULTS FROM A RANDOMIZED CLINICAL TRIAL (2002) (0)
- Extracting spurious messages from noise Extracting spurious messages from noise and risk of schizophrenia-spectrum disorders and risk of schizophrenia-spectrum disorders in a prodromal population in a prodromal population (2006) (0)
- Risk factors as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study (2011) (0)
- Is there a genetic basis to the brain abnormalities of bipolar disorder (2005) (0)
- Reply to Pharmacokinetic Drug-Drug Interactions Between Olanzapine and Valproate Need to Be Better Studied (2010) (0)
- 31 – Open-label treatment with olanzapine in adolescents with bipolar mania (2008) (0)
- The field of bipolar disorders has lost a pioneer - Charlie Bowden. (2022) (0)
- PMH21: CLINICAL AND HEALTH-RELATED QUALITY OF LIFE OUTCOMES ASSOCIATED WITH OLANZAPINE IN PATIENTS WITH BIPOLAR DISORDER AS COMPARED WITH HALOPERIDOL (2001) (0)
- Adjunctive Lumateperone (ITI-007) in the Treatment of Bipolar Depression: Results From a Randomized Placebo-Controlled Clinical Trial. (2023) (0)
- Management of acute mania. Discussion (1999) (0)
- POR4: LINGUISTIC VALIDATION OF THE SLICE/LIFE QUESTIONNAIRE (1999) (0)
- Symptoms of Schizophrenia (1995) (0)
- A Double-Blind, Placebo-controlled Trial of Divalproex and Olanzapine in Bipolar I Disorder, Mixed Episode (2009) (0)
- P.1.090 Olanzapine/fluoxetine combination improves long-term quality of life in bipolar depression (2003) (0)
- Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder. (2021) (0)
- Essentials of Clinical Psychopharmacology (2002) (0)
- P.2.f.002 Olanzapine versus divalproex and placebo for the treatment of mild to moderate mania associated with bipolar I disorder (2007) (0)
- S165. GLUTAMATERGIC ABNORMALITIES IN EARLY SCHIZOPHRENIA AND BIPOLAR DISORDER MEASURED USING WHOLE-BRAIN SPECTROSCOPY (2020) (0)
- Olanzapine in Treatment for Bipolar Disorder (2006) (0)
- Comprar Bipolar psychopharmacotherapy. Caring for the patient | M. Tohen | 9780470747216 | Wiley (2011) (0)
- Abnormal temporal lobe N-acetyl aspartate levels in first episode psychosis (1995) (0)
- P.1.128 Dysphoric mania: A controlled study of the benefits of olanzapine combined with valproate or lithium (2003) (0)
- Dr. Hegarty and Colleagues Reply (1995) (0)
- Innovative Approaches to Treatment-Resistant Psychiatric Disorders (1998) (0)
- Improved attention is associated with reductions in frontal lobe lactate levels in first episode psychosis (2003) (0)
- In memoriam--Vivek Singh. (2016) (0)
- Drs. Tohen and Lin Reply (2006) (0)
- Abstracts from ASENT 2004 Annual Meeting March 11–13, 2004 (2004) (0)
- Do lithium levels to prevent depressive episodes differ from those to prevent manic/mixed episodes in bipolar disorder? A post-hoc analysis (2007) (0)
- PMH20 THE ECONOMIC BURDEN OF BIPOLAR DISORDER IN THE UNITED STATES: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW (2019) (0)
- Correction to: Karagianis J, Rosenbluth M, Tohen M, et al. Reviewing CATIE for clinicians: balancing benefit and risk using evidence-based medicine tools. Curr Med Res Opin 2007;23:2551-57 (2011) (0)
- Detecting PTSD and self-harm among US Veterans using positive unlabeled learning (2021) (0)
- APA Diversity Awards - Past Award Winners (2014) (0)
- 408. P300 asymmetry persists at retest in first psychotic episode schizophrenia (1998) (0)
- S-24-4 New treatments for bipolar disorder (1995) (0)
- QUESTION: In patients with acute manic or mixed bipolar episodes, is a combination of olanzapine with valproate or lithium more effective than valproate or lithium alone? (2002) (0)
- 275. Is olanzapine a mood-stabilizer? (2000) (0)
- Abstracts from ASENT 2004 Annual Meeting March 11–13, 2004 (2004) (0)
- Corrigendum to bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study [Journal of Affective Disorders 217 (2017) 183-189]. (2018) (0)
- CHOICE ) : A pragmatic trial of complex treatment for a complex disorder Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (2013) (0)
- Study of Cavum Septi Pellucidi in Schizophrenia , Affective Disorder , and Schizotypal Personality Disorder (2010) (0)
- Chronbiologically-based sub-groups in bipolar I disorder: A latent profile analysis. (2021) (0)
- Abstracts from ASENT 2004 Annual Meeting March 11–13, 2004 (2004) (0)
- Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-response (2021) (0)
- Contents of the American Journal of Psychiatry (1995) (0)
This paper list is powered by the following services:
Other Resources About Mauricio Tohen
What Schools Are Affiliated With Mauricio Tohen?
Mauricio Tohen is affiliated with the following schools:
